Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Current Leases: 2024-2025

Historic Current Leases for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $1.6 million.

  • Pyxis Oncology's Current Leases rose 17.01% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 17.01%. This contributed to the annual value of $1.4 million for FY2024, which is N/A change from last year.
  • Pyxis Oncology's Current Leases amounted to $1.6 million in Q3 2025, which was up 3.95% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Current Leases ranged from a high of $1.6 million in Q3 2025 and a low of $1.0 million during Q1 2024.
  • For the 2-year period, Pyxis Oncology's Current Leases averaged around $1.4 million, with its median value being $1.5 million (2024).
  • Data for Pyxis Oncology's Current Leases shows a peak YoY spiked of 47.84% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Current Leases (Quarterly) stood at $1.4 million in 2024, then increased by 17.01% to $1.6 million in 2025.
  • Its Current Leases stands at $1.6 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.5 million for Q1 2025.